cranial nerve palsy: Injury to any of the cranial nerves or their nuclei in the brain resulting in muscle weakness.
Endpoint definition
↥Report an error or suggest an improvement for this endpoint codes
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
519972 |
1. Apply sex-specific ruleNone |
519972 |
2. Check conditionsNone |
519972 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
576 |
4. Check minimum number of eventsNone |
576 |
5. Include endpointsNone |
576 |
6. Filter based on genotype QC (FinnGen only) |
554 |
Control definitions (FinnGen only)
- Control exclude
- G6_NERPLEX
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF2
Similar endpoints
↥List of similar endpoints to
Postzoster neuralgia
based on the number of shared cases.
Similar with more cases:
- Nerve, nerve root and plexus disorders
- Neurological diseases
- Neurological diseases, wide definition
- Any event in hilmo or specialist outpatient
- Any prescribed medicine buy
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 3542 | 2189 | 1325 |
| Only index persons | 3234 | 2038 | 1196 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.05 | 0.06 | 0.04 |
| Only index persons | 0.06 | 0.07 | 0.05 |
| Median age at first event (years) | |||
| Whole population | 75.27 | 76.62 | 72.99 |
| Only index persons | 74.95 | 76.35 | 72.58 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 554 | 327 | 227 |
| Unadjusted period prevalence (%) | 0.11 | 0.12 | 0.10 |
| Median age at first event (years) | 73.01 | 72.74 | 73.40 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
CodeWAS
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 576
- Matched controls
- 5760
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
G53.0
ICD-10 Finland
Postzoster neuralgia
436.1
307.7
262
11
B02.9
ICD-10 Finland
Zoster without complication
21.8
290.0
266
218
G53.0*B02.20
ICD-10 Finland
Trigeminal neuralgia after shingles
813.3
228.4
210
*
N03AX12
ATC
[U] gabapentin; oral
12.2
206.2
302
477
J05AB11
ATC
valaciclovir; oral
11.7
197.7
295
474
N03AX16
ATC
[U] pregabalin
10.6
185.4
347
722
J05AB01
ATC
aciclovir; systemic
8.9
157.1
342
813
B02.8
ICD-10 Finland
Zoster with other complications
67.2
155.5
86
15
G53.0*B02.21
ICD-10 Finland
Postherpetic geniculate ganglionitis
1756.9
145.3
135
*
N06AX21
ATC
duloxetine; oral
7.8
92.9
154
259
B02
ICD-10 Finland
Zoster [herpes zoster]
10.4
92.2
113
132
S70
ICPC
Herpes zoster
14.0
92.2
90
75
G530, B028,
ICD-10 Finland
938.3
84.8
81
*
N02BF01
ATC
gabapentin; oral
7.5
73.5
120
196
N02AX02
ATC
tramadol; systemic, rectal
4.5
67.4
381
1734
G56.0
ICD-10 Finland
Carpal tunnel syndrome
12.3
59.8
62
56
N02BF02
ATC
pregabalin; oral
7.4
57.2
91
143
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
4.0
48.2
178
576
B02.20
ICD-10 Finland
Herpes zoster trigeminal neuralgia
121.8
42.4
45
*
N06AX16
ATC
venlafaxine; oral
4.3
41.4
126
351
N03AF01
ATC
carbamazepine; oral, rectal
6.2
40.5
74
133
N03AX09
ATC
lamotrigine; oral
7.8
37.5
54
75
H02AB06
ATC
prednisolone; systemic
3.1
37.3
361
2031
N02AA05
ATC
oxycodone; systemic
3.2
35.0
189
763
G50.0
ICD-10 Finland
Trigeminal neuralgia
59.6
33.7
39
7
N06AA09
ATC
amitriptyline; systemic
4.1
33.4
104
292
M79.2
ICD-10 Finland
Neuralgia and neuritis, unspecified
9.9
32.1
38
41
N02AJ06
ATC
codeine and paracetamol; systemic
2.7
30.7
285
1519
G51.0
ICD-10 Finland
Bell palsy
163.5
30.0
31
*
R51.80
ICD-10 Finland
Headache
3.4
28.9
125
436
N02AA59
ATC
codeine, combinations excl. psycholeptics; systemic
2.6
28.6
306
1732
B02.21
ICD-10 Finland
Herpes zoster neuralgia in another cranial nerve
65.4
27.2
31
5
GD1AA
NOMESCO Finland
Thorax X-ray examination
2.6
27.0
348
2133
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
2.6
26.4
250
1321
A01
ICPC
Pain general/multiple sites
3.7
26.3
95
294
ACC51
NOMESCO Finland
Release of median nerve
272.2
25.9
26
*
H19.2*B02.3
ICD-10 Finland
Keratitis and keratoconjunctivitis (interstitial) in zoster
26.5
25.6
35
14
N03AF02
ATC
oxcarbazepine; oral
7.3
25.3
38
55
B02.3
ICD-10 Finland
Zoster ocular disease
60.9
25.2
29
5
G530, B029,
ICD-10 Finland
+∞
24.1
23
*
A02BC02
ATC
pantoprazole; systemic
2.7
23.4
441
3139
M51.1
ICD-10 Finland
Lumbar and other intervertebral disc disorders with radiculopathy
3.2
22.1
101
361
M51.3
ICD-10 Finland
Other specified intervertebral disc degeneration
4.2
21.6
61
158
S01AD03
ATC
aciclovir; ophthalmic
5.0
21.2
47
100
M54.5
ICD-10 Finland
Low back pain
2.3
20.7
228
1260
A49.9
ICD-10 Finland
Bacterial infection, unspecified
2.9
20.7
110
428
J01DB01
ATC
cefalexin; oral
3.1
20.5
496
3848
J06.9
ICD-10 Finland
Acute upper respiratory infection, unspecified
2.3
20.4
254
1477
117
Kela drug reimbursment
Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue
4.2
20.2
56
143
M79.6
ICD-10 Finland
Pain in limb
2.2
19.8
269
1615
DM1QA
NOMESCO Finland
Paranasal sinuses X-ray examination in one projection
5.0
19.7
44
94
Z01.8
ICD-10 Finland
Other specified special examinations
2.5
19.4
154
732
ACC59
NOMESCO Finland
Decompression and freeing of adhesions of peripheral nerve: other or unspecified
47.8
19.3
23
5
R06.0
ICD-10 Finland
Dyspnoea
2.3
19.1
207
1128
R52.2
ICD-10 Finland
Other chronic pain
5.4
18.9
38
74
R53
ICD-10 Finland
Malaise and fatigue
2.3
18.9
193
1026
R51.81
ICD-10 Finland
Facial pain NOS
7.7
18.4
26
35
A02BC05
ATC
esomeprazole; systemic
2.2
18.3
265
1618
S01
ICPC
Pain/tenderness of skin
4.3
18.3
50
126
R07.4
ICD-10 Finland
Chest pain, unspecified
2.2
17.9
204
1130
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
2.7
17.6
106
438
R11
ICD-10 Finland
Nausea and vomiting
3.1
17.3
80
286
J20.9
ICD-10 Finland
Acute bronchitis, unspecified
2.4
17.3
146
710
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
2.8
17.2
95
375
L04AX01
ATC
azathioprine; systemic
4.6
17.1
42
97
R50.9
ICD-10 Finland
Fever, unspecified
2.6
17.1
115
503
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
2.1
17.0
243
1467
L28
ICPC
Limited function/disability (L)
2.4
16.9
153
767
JN3AD
NOMESCO Finland
Abdominal CT examination
2.9
16.8
90
350
N02BE01
ATC
paracetamol; systemic, rectal
3.8
16.7
537
4503
H04.10
ICD-10 Finland
Dry eye syndrome
2.9
16.5
84
317
J01EE01
ATC
sulfamethoxazole and trimethoprim; systemic
3.7
16.5
56
165
G50.1
ICD-10 Finland
Atypical facial pain
21.7
16.1
23
11
Z01.0
ICD-10 Finland
Examination of eyes and vision
2.4
16.0
136
662
J18.9
ICD-10 Finland
Pneumonia, unspecified
2.1
15.9
207
1199
R10.1
ICD-10 Finland
Pain localized to upper abdomen
2.4
15.9
128
608
N06AA10
ATC
nortriptyline; systemic
7.4
15.8
23
32
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
3.4
15.7
61
196
R03AC02
ATC
salbutamol; inhalant
2.1
15.7
328
2257
AA1DG
NOMESCO Finland
Very extensive MRI examination of brain with high intensity magnet
5.8
15.7
29
52
Z03.9
ICD-10 Finland
Observation for suspected disease or condition, unspecified
2.4
15.6
125
592
G63.0*B02.29
ICD-10 Finland
Postherpetic polyneuropathy
164.3
15.6
16
*
R10.3
ICD-10 Finland
Pain localized to other parts of lower abdomen
2.4
15.2
126
604
AA1AD
NOMESCO Finland
CT of head and brain
2.1
15.1
207
1217
XW000
NOMESCO Finland
Bone marrow biopsy
3.9
15.1
45
121
C03CA01
ATC
furosemide; systemic
2.0
14.6
260
1678
A02BC01
ATC
omeprazole; systemic
2.1
14.4
192
1115
WZC00
NOMESCO Finland
Treatment plan or consultation
2.0
14.0
211
1278
H03.1*B02.3
ICD-10 Finland
Zoster blepharitis
24.5
13.9
19
8
J01.0
ICD-10 Finland
Acute maxillary sinusitis
2.3
13.8
131
664
N01
ICPC
Headache
2.8
13.6
71
271
SPAT1263
SPAT
Sampling
1.9
13.5
261
1718
R02
ICPC
Shortness of breath/dyspnoea
2.4
13.3
102
471
R52.0
ICD-10 Finland
Acute pain
4.7
13.2
31
69
DM1AA
NOMESCO Finland
Paranasal sinuses X-ray examination without contrast
4.8
13.2
30
65
J45.9
ICD-10 Finland
Asthma, unspecified
2.2
12.8
131
682
M03BX02
ATC
tizanidine; oral
1.9
12.8
324
2320
M70.6
ICD-10 Finland
Trochanteric bursitis
2.4
12.8
96
439
A46
ICD-10 Finland
Erysipelas
2.3
12.7
113
556
J32.0
ICD-10 Finland
Chronic maxillary sinusitis
3.2
12.6
52
173
GD1DD
NOMESCO Finland
High resolution CT examination of lungs
3.4
12.6
46
142
R29.8
ICD-10 Finland
Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems
2.9
12.6
64
241
WZB00
NOMESCO Finland
Telephone prescription or other care instructions
2.1
12.5
159
899
G44.2
ICD-10 Finland
Tension-type headache
2.5
12.5
87
384
H90.3
ICD-10 Finland
Sensorineural hearing loss, bilateral
2.1
12.5
143
779
XCW99
NOMESCO Finland
Other investigative procedure of eye
2.4
12.3
89
400
H01
ICPC
Ear pain/earache
2.7
12.3
71
286
L03
ICPC
Low back symptom/complaint
2.0
12.2
161
923
ZX120
NOMESCO Finland
Intravenous
2.6
12.1
77
325
H22.0*B02.3
ICD-10 Finland
Zoster iridocyclitis
27.4
12.1
16
6
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
1.9
11.9
283
1968
L03AA02
ATC
filgrastim; parenteral
4.4
11.9
30
71
A41.9
ICD-10 Finland
Sepsis, unspecified
3.9
11.8
36
98
R05
ICPC
Cough
2.0
11.6
150
851
R05
ICD-10 Finland
Cough
2.1
11.6
134
730
R03AK06
ATC
salmeterol and fluticasone; inhalant
2.3
11.6
103
506
W01
ICD-10 Finland
Fall on same level from slipping, tripping and stumbling
1.9
11.5
219
1416
S01XA20
ATC
artificial tears and other indifferent preparations; ophthalmic
1.8
11.5
284
1992
G530, B022,
ICD-10 Finland
+∞
11.5
11
*
H62.1*B02.8
ICD-10 Finland
Otitis externa in zoster
122.4
11.5
12
*
N03AE01
ATC
clonazepam; systemic
3.4
11.5
42
130
R07.3
ICD-10 Finland
Other chest pain
2.6
11.4
73
309
I50.9
ICD-10 Finland
Heart failure, unspecified
2.1
11.3
135
743
M25.5
ICD-10 Finland
Pain in joint
1.9
11.3
176
1065
NA3CG
NOMESCO Finland
Lumbar spine extensive MRI examination with high intensity magnet
4.2
11.3
30
74
N06CA01
ATC
amitriptyline and psycholeptics; systemic
2.5
11.2
73
311
S18
ICPC
Laceration/cut
1.8
11.2
275
1922
R03BA05
ATC
fluticasone; inhalant
2.2
11.1
113
585
ND2AA
NOMESCO Finland
Hand and fingers X-ray examination
2.8
11.1
59
227
NA3AA
NOMESCO Finland
Lumbar spine X-ray examination without contrast
2.6
11.1
68
282
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
2.4
11.1
79
352
R06AE07
ATC
cetirizine; oral
1.8
11.0
238
1597
NA3BG
NOMESCO Finland
Lumbar spine MRI examination with high intensity magnet
2.7
11.0
62
246
R42
ICD-10 Finland
Dizziness and giddiness
1.9
11.0
164
977
G56.2
ICD-10 Finland
Lesion of ulnar nerve
18.2
10.8
16
9
A03FA01
ATC
metoclopramide; systemic, rectal
2.0
10.7
149
865
TDM10
NOMESCO Finland
Puncture of maxillary antrum
4.1
10.7
30
77
N30.0
ICD-10 Finland
Acute cystitis
2.1
10.7
115
608
TAB00
NOMESCO Finland
Lumbar puncture
3.6
10.6
35
101
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
1.9
10.6
191
1208
A07AA02
ATC
nystatin; oral
2.9
10.5
50
181
J01FA10
ATC
azithromycin; systemic
1.8
10.5
294
2124
K80.0
ICD-10 Finland
Calculus of gallbladder with acute cholecystitis
3.5
10.4
36
107
K08.80
ICD-10 Finland
Toothache NOS
3.0
10.4
47
165
N05CF01
ATC
zopiclone; oral
1.8
10.4
216
1425
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
2.0
10.4
147
857
WX110
NOMESCO Finland
Infiltration anesthesia
1.8
10.4
370
2864
E87.1
ICD-10 Finland
Hypo-osmolality and hyponatraemia
3.1
10.3
43
144
H57.1
ICD-10 Finland
Ocular pain
4.2
10.3
28
70
H02AB04
ATC
methylprednisolone; systemic
2.2
10.3
100
507
SPAT1254
SPAT
Administration of medicine
2.1
10.3
107
558
J01MA12
ATC
levofloxacin; systemic
2.0
10.3
131
737
NH3AA
NOMESCO Finland
Foot and toes X-ray examination
2.7
10.1
56
220
UJF32
NOMESCO Finland
Coloscopy
1.9
10.1
172
1067
M48.0
ICD-10 Finland
Spinal stenosis
2.2
10.0
89
436
M01AH05
ATC
etoricoxib; oral
1.8
10.0
317
2361
J01AA02
ATC
doxycycline; systemic
1.9
9.9
450
3727
AA1BG
NOMESCO Finland
Standard MRI examination of brain with high intensity magnet
2.6
9.9
59
241
X59
ICD-10 Finland
Exposure to unspecified factor
2.1
9.9
112
603
R01AD12
ATC
fluticasone furoate; nasal
1.9
9.8
148
882
S29
ICPC
Skin symptom/complaint other
2.0
9.7
118
651
SPAT1253
SPAT
Initiation, adjustment, discontinuation or repetition of medication
1.8
9.7
184
1177
A99
ICPC
Disease/condition unspecnature/site
2.5
9.6
66
288
M54.9
ICD-10 Finland
Dorsalgia, unspecified
2.4
9.6
73
334
L17
ICPC
Foot/toe symptom/complaint
1.8
9.6
171
1073
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
2.5
9.5
62
264
K59.09
ICD-10 Finland
Constipation, unspecified
2.7
9.5
54
215
K57.3
ICD-10 Finland
Diverticular disease of large intestine without perforation or abscess
1.9
9.5
133
772
B02.2
ICD-10 Finland
Zoster with other nervous system involvement
101.6
9.4
10
*
R04.0
ICD-10 Finland
Epistaxis
2.5
9.4
60
253
G55.1*M51.1
ICD-10 Finland
Compression of nerve roots and nerve plexus in disc diseases in the lumbar region and other regions
12.6
9.4
16
13
A04
ICPC
Weakness/tiredness general
2.0
9.3
107
578
M54.4
ICD-10 Finland
Lumbago with sciatica
2.1
9.3
95
491
S19
ICPC
Skin injury other
3.3
9.2
35
111
R52.9
ICD-10 Finland
Pain, unspecified
2.4
9.1
68
308
Z50.9
ICD-10 Finland
Care involving use of rehabilitation procedure, unspecified
3.7
9.1
29
82
M01AB05
ATC
diclofenac; systemic, rectal
1.7
9.1
355
2773
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
2.9
9.1
42
150
SPAT1301
SPAT
No procedures
1.8
9.0
200
1335
R23.3
ICD-10 Finland
Spontaneous ecchymoses
4.4
8.9
22
51
TAC00
NOMESCO Finland
Peripheral nerve block
24.4
8.9
12
5
N29
ICPC
Neurological sympt/complt other
5.0
8.9
19
39
TNX10
NOMESCO Finland
Arthrocentesis, unspecified region, unspecified region
2.8
8.9
45
169
NK4XE
NOMESCO Finland
Joint ultrasound examination not elsewhere classified
2.9
8.8
43
158
F32.9
ICD-10 Finland
Depressive episode, unspecified
2.4
8.8
66
300
NB1AA
NOMESCO Finland
Shoulder X-ray examination without contrast
2.6
8.8
54
224
N18.9
ICD-10 Finland
Chronic kidney disease, unspecified
2.6
8.8
53
218
Z71.8
ICD-10 Finland
Other specified counselling
1.8
8.7
173
1115
L05
ICPC
Flank/axilla symptom/complaint
2.7
8.7
48
188
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
1.7
8.7
235
1653
D07AC01
ATC
betamethasone; topical
1.7
8.7
207
1407
Z03.3
ICD-10 Finland
Observation for suspected nervous system disorder
2.8
8.7
44
165
Z50.8
ICD-10 Finland
Care involving use of other rehabilitation procedures
2.6
8.7
53
219
S20.2
ICD-10 Finland
Contusion of thorax
3.1
8.7
37
126
J02AC01
ATC
fluconazole; systemic
1.7
8.5
199
1343
NA3EA
NOMESCO Finland
Lumbar spine X-ray examination with flexion
4.3
8.5
22
53
L15
ICPC
Knee symptom/complaint
1.8
8.5
140
852
202
Kela drug reimbursment
Connective tissue diseases, rheumatoid arthritis and comparable disease
2.2
8.5
75
365
M23.9
ICD-10 Finland
Internal derangement of knee, unspecified
2.6
8.5
50
203
H60.9
ICD-10 Finland
Otitis externa, unspecified
2.7
8.5
46
179
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
2.0
8.5
103
567
SPAT1215
SPAT
Assessment of need for medical rehabilitation
3.4
8.5
31
96
M75.1
ICD-10 Finland
Rotator cuff syndrome
1.8
8.4
138
839
M79.1
ICD-10 Finland
Myalgia
2.1
8.4
84
430
NK6QA
NOMESCO Finland
Measurement of bone density from two or more locations with X-ray
2.7
8.4
47
186
M04AA01
ATC
allopurinol; systemic
2.0
8.4
98
532
SPAT1216
SPAT
Assessment of functional ability
1.9
8.3
118
684
L11
ICPC
Wrist symptom/complaint
2.6
8.3
50
205
N06AX11
ATC
mirtazapine; oral
1.7
8.3
197
1334
M10.9
ICD-10 Finland
Gout, unspecified
2.5
8.3
53
224
M54.3
ICD-10 Finland
Sciatica
2.9
8.3
38
135
WW200
NOMESCO Finland
Immunization
4.3
8.3
21
50
SPAT1223
SPAT
Implementation of physical therapy rehabilitation plan
1.7
8.2
176
1158
H02AB09
ATC
hydrocortisone; systemic
4.9
8.2
18
38
UDC00
NOMESCO Finland
Ear microscopy
2.5
8.1
54
232
J01CA04
ATC
amoxicillin; systemic
1.8
8.1
436
3660
J01FA09
ATC
clarithromycin; systemic
1.8
8.1
165
1070
WYA05
NOMESCO Finland
Emergency visit or other similar visit involving procedures
1.7
8.0
228
1617
DM1AD
NOMESCO Finland
CT of paranasal sinuses and face area
3.5
8.0
28
84
L50.0
ICD-10 Finland
Allergic urticaria
4.4
8.0
20
47
R07.0
ICD-10 Finland
Pain in throat
3.1
7.9
34
116
XG470
NOMESCO Finland
Measurement of diffusion capastity of the lungs
3.9
7.9
23
61
A06AD11
ATC
lactulose; oral
1.9
7.9
115
673
SFA10
NOMESCO Finland
One-surface restoration
1.6
7.9
267
1981
JN3BD
NOMESCO Finland
Extensive abdominal CT
2.3
7.8
63
295
SPAT1153
SPAT
Removal of sutures
1.7
7.8
189
1282
XG410
NOMESCO Finland
Flow-volume spirometry
3.1
7.7
32
107
B02.29
ICD-10 Finland
Herpes zoster polyneuropathy
45.6
7.7
9
*
L04AA01
ATC
[U] ciclosporin
7.6
7.7
17
23
J01MA02
ATC
ciprofloxacin; systemic
1.7
7.7
238
1721
Z2446
NOMESCO Finland
Social worker
2.5
7.6
48
201
ZXE03
NOMESCO Finland
Procedure duration 20 to 29 minutes
2.8
7.6
39
147
M03BC01
ATC
orphenadrine (citrate); systemic
1.9
7.6
111
648
F32.10
ICD-10 Finland
Moderate depressive episode without somatic syndrome
2.7
7.6
40
153
B00.9
ICD-10 Finland
Herpesviral infection, unspecified
18.7
7.6
11
6
L08
ICPC
Shoulder symptom/complaint
1.8
7.6
121
727
A03
ICPC
Fever
2.1
7.6
79
411
M54.6
ICD-10 Finland
Pain in thoracic spine
2.6
7.5
45
184
F32.00
ICD-10 Finland
Mild depressive episode without somatic syndrome
3.6
7.5
24
68
FB1BD
NOMESCO Finland
Extensive CT examination of arteria pulmonalis
2.3
7.5
57
261
H02.4
ICD-10 Finland
Ptosis of eyelid
3.4
7.5
26
78
J01FA06
ATC
roxithromycin; oral
1.6
7.4
224
1606
M01AE01
ATC
ibuprofen; systemic, rectal
1.9
7.4
478
4161
XQ800
NOMESCO Finland
Prick test
2.8
7.4
38
144
ZYC01
NOMESCO Finland
Remote contact by phone
2.7
7.4
39
150
D07AB02
ATC
hydrocortisone butyrate; topical
1.7
7.4
170
1137
NA1BG
NOMESCO Finland
Cervical spine MRI examination with high intensity magnet
3.3
7.3
27
84
P01BA02
ATC
hydroxychloroquine; oral
2.3
7.3
55
250
Z01.2
ICD-10 Finland
Dental examination
1.6
7.3
219
1566
C08CA01
ATC
amlodipine; oral
1.6
7.3
253
1876
WX109
NOMESCO Finland
Extensive surface anesthesy of skin with external ointment or geel
+∞
7.3
7
*
N01BX04
ATC
capsaicin; inhalant, oral, topical, transdermal
+∞
7.3
7
*
G530, B0229,
ICD-10 Finland
+∞
7.3
7
*
NG1AA
NOMESCO Finland
Knee X-ray examination without contrast
2.1
7.3
77
402
L04AA06
ATC
mycophenolic acid; systemic
6.4
7.3
18
29
L88
ICPC
Rheumatoid/seropositive arthritis
3.2
7.3
29
95
WW500
NOMESCO Finland
Blood transfusion
2.8
7.3
35
128
J45.1
ICD-10 Finland
Nonallergic asthma
2.4
7.2
50
219
L04AX03
ATC
methotrexate; systemic
2.3
7.2
58
272
SPAT1255
SPAT
Intravenous administration of medicine
2.4
7.2
48
207
L29.9
ICD-10 Finland
Pruritus, unspecified
3.5
7.2
24
70
H53.1
ICD-10 Finland
Subjective visual disturbances
2.6
7.2
43
176
TQW99
NOMESCO Finland
Other minor procedure on skin
2.6
7.2
43
176
SPAT1325
SPAT
Vaccination
1.6
7.1
217
1556
DMB20
NOMESCO Finland
Functional endoscopic opening of maxillary antrum
3.0
7.1
31
107
JN4AD
NOMESCO Finland
Body CT examination
2.1
7.1
66
328
A06AC01
ATC
ispaghula (psylla seeds); oral
1.7
7.1
164
1096
SAA03
NOMESCO Finland
Extended examination of mouth
1.7
7.0
182
1252
SAA01
NOMESCO Finland
Simple examination of mouth
1.6
7.0
348
2805
C07AB07
ATC
bisoprolol; oral
1.6
7.0
318
2510
SPAT1222
SPAT
Counselling/guidance promoting independent living
1.8
6.9
110
659
D72.8
ICD-10 Finland
Other specified disorders of white blood cells
14.0
6.9
11
8
J01FF01
ATC
clindamycin; systemic
1.7
6.9
152
1001
M01AE02
ATC
naproxen; oral, rectal
1.6
6.9
292
2262
S01CA01
ATC
dexamethasone and antiinfectives; ophthalmic
1.6
6.9
232
1702
N10
ICD-10 Finland
Acute tubulo-interstitial nephritis
1.9
6.9
95
544
L02
ICPC
Back symptom/complaint
2.2
6.9
58
277
127
Kela drug reimbursment
Transplant complication
6.8
6.9
16
24
FM1AE
NOMESCO Finland
Standard cardiac ultrasound examination
1.8
6.8
125
781
R03AK08
ATC
formoterol and beclometasone; inhalant
3.0
6.8
30
104
SPAT1229
SPAT
Assessment of need for aid
2.2
6.8
60
292
E0000UV, ,
ATC
1.6
6.8
226
1653
N39.0
ICD-10 Finland
Urinary tract infection, site not specified
1.8
6.8
110
664
R5140
NOMESCO Finland
Monitoring the use of the aid
2.1
6.7
66
335
R03BB04
ATC
tiotropium bromide; inhalant
2.0
6.7
73
385
Z76.0
ICD-10 Finland
Issue of repeat prescription
1.8
6.7
122
761
H15.1
ICD-10 Finland
Episcleritis
7.9
6.6
14
18
M01AE03
ATC
ketoprofen; systemic, rectal
1.6
6.6
212
1533
M54.1
ICD-10 Finland
Radiculopathy
3.4
6.6
23
69
J45.8
ICD-10 Finland
Mixed asthma
3.4
6.6
23
69
K04.5
ICD-10 Finland
Chronic apical periodontitis
1.7
6.6
135
870
SPAT1256
SPAT
Intramuscular and subcutaneous injection
1.6
6.5
237
1764
EBA10
NOMESCO Finland
Operative extraction of tooth
2.3
6.5
49
223
C01DA14
ATC
isosorbide mononitrate; oral
1.7
6.5
126
800
ZY020
NOMESCO Finland
Telephone, letter or other consultation without direct patient contact
2.4
6.5
43
185
R05DA20
ATC
opium alkaloids and derivatives - combinations
1.7
6.5
147
974
SPAT1249
SPAT
Treatment-related counselling outside office
1.6
6.5
212
1541
N03
ICPC
Pain face
14.5
6.4
10
7
TPH04
NOMESCO Finland
Cathetrisation of vein
1.7
6.4
127
811
XG412
NOMESCO Finland
Flow-volume spirometry with bronchospasmolysis
2.7
6.4
35
137
M01AC06
ATC
meloxicam; systemic, rectal
1.6
6.4
205
1481
C01DA08
ATC
isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal
1.6
6.4
175
1217
R4120
NOMESCO Finland
Occupational therapy
2.5
6.4
41
174
S22.3
ICD-10 Finland
Fracture of rib
2.3
6.4
48
219
M05BA04
ATC
alendronic acid; oral
2.0
6.4
74
400
NA3AD
NOMESCO Finland
Lumbar spine and sacrum CT examination
3.5
6.3
21
61
WD415
NOMESCO Finland
Demanding antibody therapy of methastized malignancy
6.1
6.3
16
27
SPAT1144
SPAT
Treatment of reopened or infected surgical wound
2.3
6.3
47
213
R01AD09
ATC
mometasone; nasal
1.6
6.3
219
1612
R5110
NOMESCO Finland
Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it
2.0
6.3
74
402
J01MA14
ATC
moxifloxacin; systemic
2.1
6.3
59
295
ACC53
NOMESCO Finland
Release of ulnar nerve
+∞
6.3
6
*
EB1AA
NOMESCO Finland
Intraoral radiographic dental examination
1.6
6.3
259
1982
B01.9
ICD-10 Finland
Varicella without complication
27.0
6.2
8
*
N05AH04
ATC
quetiapine; oral
1.9
6.2
90
523
K02.1
ICD-10 Finland
Caries of dentine
1.6
6.2
272
2107
K08.1
ICD-10 Finland
Loss of teeth due to accident, extraction or local periodontal disease
2.0
6.2
73
397
D01
ICPC
Abdominal pain/cramps general
2.1
6.2
63
325
M03BA52
ATC
carisoprodol, combinations excl. psycholeptics; oral
3.0
6.1
26
89
R03BA01
ATC
beclometasone; inhalant
1.9
6.1
77
429
1XC02, ,
NOMESCO Finland
10.2
6.1
11
11
T82
ICPC
Obesity
3.4
6.1
21
63
NA2AA
NOMESCO Finland
Thoracal spine X-ray examination without contrast
3.4
6.1
21
63
H13
ICPC
Plugged feeling ear
1.7
6.0
123
791
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
103
321
3.69
28.31
3.6
2.9
8.94
10.59
g/l
2.90
96
286
338
2095
2.48
24.84
10.4
5.7
25.27
26.35
%
0.88
325
1950
376
2447
2.55
24.84
8.1
6.0
10.94
12.22
umol/l
1.76
369
2315
261
1448
2.47
24.39
2.7
2.1
284.53
260.81
u/l
0.09
243
1355
334
2073
2.45
24.27
9.7
5.4
59.78
58.49
%
1.04
320
1934
375
2457
2.51
24.10
9.1
6.1
1.21
1.21
mmol/l
0.39
314
2093
330
2048
2.43
23.82
10.1
5.5
2.70
2.76
%
0.17
318
1901
352
2250
2.45
23.75
7.8
5.4
1.20
1.21
mmol/l
0.89
320
2025
134
542
2.92
23.69
6.9
3.9
265.65
244.93
u/l
0.73
129
511
480
3572
3.06
23.33
11.5
7.2
76.36
79.93
u/l
1.05
466
3323
387
2595
2.50
23.28
13.4
8.7
4.60
4.20
e9/l
2.07
351
2254
28
31
9.44
23.13
1.3
1.3
—
—
—
0
0
42
75
5.96
22.90
3.8
5.9
147.43
196.17
iu/ml
—
7
12
186
904
2.56
22.84
2.8
1.8
—
—
—
0
0
458
3358
2.78
22.27
6.5
4.0
15.17
13.79
mm/h
1.01
440
3041
397
2773
2.39
20.54
6.9
4.7
6.86
6.72
mmol/l
0.77
381
2598
151
699
2.57
20.22
2.9
2.2
2.30
2.31
g/l
0.06
143
647
304
1910
2.25
20.14
3.6
2.6
287.29
131.37
ug/l
1.21
281
1725
330
2153
2.25
19.81
7.2
4.3
34.08
34.85
g/l
1.46
306
1990
144
660
2.58
19.62
3.0
2.2
21.52
21.93
%
0.12
125
573
30
19
16.58
18.99
1.3
1.2
—
—
—
0
0
351
2392
2.20
18.33
23.5
18.1
1.34
1.33
inr
0.03
122
665
38
80
5.01
17.30
2.2
1.3
80.00
—
titre
—
5
0
293
1894
2.11
17.14
6.0
3.9
40.16
59.25
ng/l
0.51
231
1420
235
1398
2.15
17.09
3.3
2.4
53.99
62.24
u/l
1.17
221
1289
279
1777
2.11
16.91
4.9
3.3
—
—
—
0
0
181
977
2.24
16.75
2.1
1.7
1.14
1.32
mg/l
0.59
146
760
264
1667
2.08
16.17
4.4
3.0
1832.43
1551.91
ng/l
0.48
236
1447
441
3376
2.31
16.16
4.3
3.8
15.24
15.01
pmol/l
1.11
404
2998
97
407
2.66
15.57
3.3
2.6
65.17
66.13
g/l
0.57
89
367
370
2673
2.07
15.34
3.8
3.0
58.83
51.58
u/l
0.69
342
2439
26
22
12.32
14.70
2.7
2.4
—
—
—
0
0
146
756
2.25
14.70
4.4
3.2
0.79
0.81
mmol/l
1.98
133
701
285
1896
2.00
14.66
2.8
2.2
80.25
79.09
nmol/l
0.29
253
1653
44
119
3.92
14.61
2.0
1.7
—
—
—
0
0
184
1048
2.11
14.54
3.8
2.6
5.56
5.42
e6/l
0.04
166
951
214
1290
2.05
14.50
2.6
2.1
3.26
3.15
mg/l
0.25
182
1085
91
384
2.63
14.39
2.8
1.9
345.30
400.88
nmol/l
1.54
86
346
29
58
5.21
13.98
2.3
2.9
1143.33
654.63
u/ml
—
6
8
526
4462
3.06
13.84
32.6
15.7
23.81
25.95
mg/l
0.75
469
3594
194
1148
2.04
13.69
4.2
2.6
2184.39
9118.92
umol/l
2.22
172
975
124
619
2.28
13.53
7.6
4.4
1.04
1.03
mmol/l
0.21
116
559
128
650
2.25
13.39
2.6
1.8
—
—
—
0
0
127
647
2.24
13.17
2.5
1.8
—
—
—
0
0
84
360
2.56
12.82
2.0
1.6
—
—
—
0
0
259
1738
1.89
12.34
3.7
3.3
2.36
2.35
mmol/l
0.11
228
1497
116
585
2.23
12.26
3.9
2.4
2.01
1.82
%
0.86
107
513
32
79
4.23
12.00
1.7
1.6
—
—
—
0
0
73
305
2.60
11.70
1.7
1.4
—
—
—
0
0
45
144
3.31
11.65
3.3
1.6
286.67
200.00
titre
—
6
7
167
994
1.96
11.24
6.7
4.0
600.03
254.05
ng/l
0.53
148
847
28
66
4.41
11.14
1.6
1.6
—
—
—
0
0
29
71
4.25
11.00
1.7
1.5
—
—
—
0
0
214
1391
1.86
10.96
4.8
3.2
0.49
0.56
e6/l
0.16
171
1073
27
63
4.45
10.87
1.7
1.6
—
—
—
0
0
254
1750
1.81
10.69
5.7
3.8
45.17
148.10
e6/l
1.81
196
1266
226
1511
1.82
10.45
5.1
3.3
31.07
119.08
e6/l
1.29
186
1184
310
2279
1.78
10.36
5.2
4.0
0.00
0.00
estimate
-0.00
70
460
311
2290
1.78
10.32
3.1
2.6
—
—
—
0
0
294
2133
1.77
10.24
2.5
2.1
92.94
93.97
pmol/l
0.13
169
1069
37
114
3.40
10.17
2.1
1.7
—
—
—
0
0
44
151
3.07
10.16
4.7
3.6
149.55
109.72
mg/l
0.16
34
117
44
151
3.07
10.16
4.7
3.6
43.24
51.64
mg/l
0.15
36
119
118
645
2.04
9.99
1.4
1.2
64.21
40.97
iu/ml
0.40
36
207
66
287
2.47
9.71
6.7
3.6
2.25
1.82
mmol/l
0.35
49
223
134
775
1.95
9.64
2.3
1.9
30.06
29.74
s
0.26
128
747
307
2280
1.74
9.64
6.5
5.3
0.00
0.00
estimate
-0.00
68
416
205
1362
1.78
9.48
4.3
3.1
33.70
33.76
u/l
0.00
197
1294
309
2306
1.73
9.48
5.4
4.0
0.00
0.00
estimate
-0.00
64
416
57
234
2.59
9.45
1.6
1.8
1.39
1.59
g/l
0.77
49
211
484
4134
2.07
9.41
5.7
4.7
1.93
2.32
mu/l
0.71
454
3693
22
32
7.11
9.40
1.5
1.1
—
—
—
0
0
111
607
2.03
9.35
1.3
1.2
7.94
12.90
u/ml
0.55
34
220
531
4724
2.59
9.06
34.8
18.7
4.01
3.99
mmol/l
0.97
524
4570
45
167
2.84
9.06
2.0
2.1
44.19
39.02
u/l
0.78
37
148
193
1274
1.77
9.05
1.9
1.6
21.34
20.99
nmol/l
0.10
174
1077
530
4718
2.54
8.90
34.6
18.6
139.26
139.59
mmol/l
1.96
523
4574
23
56
4.24
8.79
1.3
1.3
—
—
—
0
0
142
862
1.86
8.73
3.7
2.8
1.51
1.25
e6/l
0.31
90
492
91
474
2.09
8.71
3.2
2.5
5.06
6.36
ug/l
0.30
82
406
285
2120
1.68
8.52
3.5
2.5
—
—
—
0
0
86
447
2.09
8.26
2.6
2.4
29.24
30.38
u/l
0.19
75
370
45
176
2.69
8.21
2.9
3.1
—
—
—
0
0
107
603
1.95
8.21
6.5
6.8
2.22
1.33
mmol/l
1.73
89
485
50
207
2.55
8.15
1.6
1.2
660.91
211.00
u/ml
0.64
45
187
529
4740
2.42
8.13
17.6
10.5
23.38
24.29
u/l
0.83
518
4537
68
326
2.23
8.01
9.8
6.5
25.30
24.58
mmol/l
0.84
68
310
50
211
2.50
7.84
3.1
1.8
—
—
—
0
0
14
13
11.00
7.83
3.1
2.0
—
—
—
0
0
39
146
2.79
7.74
1.2
1.2
0.30
2.34
u/ml
—
6
12
165
1082
1.74
7.72
1.7
1.7
445.93
6857575.53
pmol/l
0.50
137
875
18
40
4.61
7.70
1.8
1.5
—
—
—
0
0
26
79
3.40
7.33
2.1
1.7
—
—
—
0
0
26
79
3.40
7.33
2.1
1.7
—
—
—
0
0
20
51
4.03
7.21
1.6
1.8
—
—
—
0
0
168
1133
1.68
7.00
3.2
2.2
—
—
—
0
0
45
191
2.47
6.98
2.8
1.7
—
—
—
0
0
71
366
2.07
6.95
2.3
1.6
—
—
—
0
0
24
72
3.43
6.90
1.9
1.5
—
—
—
0
0
20
53
3.87
6.86
1.8
1.6
—
—
—
0
0
72
375
2.05
6.86
4.3
3.2
97.96
87.25
ng/l
0.60
63
321
28
94
3.08
6.74
1.2
1.2
16.95
11.60
e6/l
0.19
22
68
28
94
3.08
6.74
1.3
1.3
30.91
1425.85
e6/l
0.59
22
72
15
21
7.30
6.74
3.7
3.8
—
—
—
0
0
35
135
2.70
6.59
1.3
1.6
—
—
—
0
0
477
4197
1.79
6.53
6.9
6.0
41.20
40.23
mmol/mol
1.34
433
3842
179
1246
1.63
6.52
6.0
4.3
0.00
0.00
estimate
-0.00
63
402
127
811
1.73
6.41
4.1
3.0
1.66
2.65
e6/l
0.94
75
444
89
513
1.87
6.32
4.1
2.8
7.46
9.35
umol/l
0.73
76
449
89
514
1.87
6.28
3.8
3.2
2.85
1.92
mmol/l
1.96
81
424
494
4406
1.85
6.28
5.5
4.8
6.04
6.00
mmol/l
0.20
450
3936
26
88
3.05
6.19
2.3
1.8
—
—
—
0
0
38
158
2.50
6.17
1.4
1.2
—
—
—
0
0
67
356
2.00
6.04
5.3
3.1
57.91
60.33
ml/min/173m2
0.19
33
156
198
1439
1.57
5.93
3.9
3.0
6.66
7.00
mmol/l
0.58
167
1199
9
6
15.20
5.92
1.2
1.2
84.67
78.17
%
—
9
6
533
4902
2.17
5.81
44.4
23.1
238.40
243.54
e9/l
0.91
523
4747
19
55
3.54
5.77
1.2
1.4
—
—
—
0
0
19
55
3.54
5.77
1.2
1.4
—
—
—
0
0
19
55
3.54
5.77
1.2
1.4
—
—
—
0
0
533
4904
2.16
5.77
44.3
23.1
4.30
4.40
e12/l
4.56
523
4731
157
1088
1.61
5.72
2.0
1.8
1140.97
1229.25
nmol/l
0.64
125
807
129
851
1.66
5.72
1.2
1.2
0.67
1.60
u/ml
2.08
30
211
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
14
23
6.21
5.72
1.3
1.2
—
—
—
0
0
19
56
3.47
5.63
1.2
1.4
—
—
—
0
0
19
56
3.47
5.63
1.2
1.4
—
—
—
0
0
19
56
3.47
5.63
1.2
1.4
—
—
—
0
0
532
4903
2.11
5.54
43.9
23.2
38.70
39.33
%
1.36
497
4530
39
173
2.35
5.53
3.4
2.1
9.71
10.31
g/l
0.34
34
149
41
186
2.30
5.52
3.9
2.0
7.41
7.41
g/l
0.00
35
163
41
186
2.30
5.52
3.9
2.0
—
—
—
0
0
41
186
2.30
5.52
3.9
2.0
3.43
3.57
g/l
0.32
36
163
27
100
2.78
5.51
1.2
1.4
—
—
—
0
0
475
4233
1.70
5.48
28.0
14.9
70.90
74.64
ml/min/173m2
2.99
409
3484
83
490
1.81
5.44
7.1
7.5
115.23
120.18
g/l
1.53
83
477
15
29
5.28
5.42
1.9
1.5
—
—
—
0
0
31
125
2.56
5.38
1.9
1.5
—
—
—
0
0
9
8
11.40
5.30
2.7
1.6
—
—
—
0
0
38
170
2.32
5.29
4.1
2.1
2.87
3.05
g/l
0.55
33
147
13
22
6.02
5.24
1.2
1.5
—
—
—
0
0
17
49
3.54
5.21
1.4
1.3
100.38
128.75
u/ml
—
8
8
200
1494
1.52
5.15
4.1
3.6
12.98
7.81
mg/mmol
0.66
133
945
12
19
6.42
5.10
1.2
1.1
—
—
—
0
0
36
160
2.33
5.09
4.2
2.4
1.56
1.05
g/l
0.29
29
134
13
23
5.76
5.09
1.2
1.2
2.95
1.93
mmol/l
0.44
13
23
16
45
3.63
5.08
2.4
2.5
—
—
—
0
0
30
124
2.50
4.96
1.7
1.6
—
—
—
0
0
13
24
5.52
4.94
2.1
1.5
—
—
—
0
0
12
20
6.10
4.93
1.2
1.2
—
—
—
0
0
30
126
2.46
4.81
1.8
1.4
—
—
—
0
0
13
25
5.29
4.79
2.1
1.5
—
—
—
0
0
225
1743
1.48
4.78
5.6
4.3
—
—
—
0
0
80
486
1.75
4.76
3.7
3.1
314.80
247.55
ng/l
0.46
75
454
11
18
6.21
4.62
2.1
3.5
828.36
1091.00
u/ml
0.37
11
18
15
36
4.25
4.54
1.0
1.0
—
—
—
0
0
8
8
10.12
4.53
1.0
1.0
—
—
—
0
0
18
61
3.01
4.32
9.1
2.1
32.72
32.33
pg
0.11
18
61
21
78
2.76
4.29
1.1
1.2
—
2.40
—
0
8
24
96
2.57
4.27
4.7
2.5
14.01
15.78
%
1.37
14
43
463
4175
1.56
4.26
4.6
4.0
1.39
1.25
mmol/l
3.59
416
3729
16
51
3.20
4.23
2.2
1.7
—
—
—
0
0
16
51
3.20
4.23
2.2
1.7
—
—
—
0
0
16
51
3.20
4.23
2.2
1.7
—
—
—
0
0
25
103
2.49
4.19
3.9
2.2
119.85
126.52
g/l
0.63
20
71
475
4318
1.57
4.10
5.1
4.4
1.42
1.48
mmol/l
2.16
430
3899
8
10
8.09
4.07
1.1
1.2
—
—
—
0
0
19
69
2.81
4.05
3.7
3.1
4.07
4.62
e9/l
0.68
19
69
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
35
170
2.13
4.05
3.8
2.4
0.32
0.34
u/ml
0.13
26
99
17
58
2.99
4.04
2.5
1.6
—
—
—
0
0
489
4484
1.60
3.97
5.7
5.1
2.59
2.64
mmol/l
0.54
448
4055
22
89
2.53
3.84
1.4
1.3
—
—
—
0
0
12
28
4.35
3.83
2.4
2.0
—
—
—
0
0
12
28
4.35
3.83
2.4
2.0
—
—
—
0
0
477
4360
1.55
3.81
5.2
4.5
4.50
4.53
mmol/l
0.26
431
3964
18
66
2.78
3.78
1.1
1.1
—
—
—
0
0
138
1010
1.48
3.77
6.1
4.5
1.02
1.02
kg/l
0.37
18
140
17
61
2.84
3.72
1.0
1.0
—
—
—
0
0
73
464
1.66
3.69
2.2
2.1
0.20
0.20
g/l
0.05
66
430
19
73
2.66
3.67
5.1
3.5
59.00
60.16
%
0.17
19
73
32
158
2.09
3.57
3.7
3.2
0.94
0.87
nmol/l
0.27
26
126
14
46
3.09
3.55
1.2
1.2
—
—
—
0
0
8
13
6.22
3.51
2.8
2.2
45387.50
35661.92
ug/l
—
8
13
65
409
1.66
3.42
6.8
3.6
1.22
1.22
mmol/l
0.01
56
357
23
101
2.33
3.40
1.3
1.4
3812.92
23341.90
e6/l
1.87
13
68
139
1041
1.44
3.34
3.4
3.1
2.47
2.46
mmol/l
0.40
121
919
36
192
1.93
3.28
8.2
3.8
24.58
24.94
mmol/l
0.25
31
179
25
116
2.21
3.27
2.0
1.6
—
—
—
0
0
13
43
3.07
3.27
1.4
1.1
—
—
—
0
0
30
150
2.05
3.26
3.3
2.1
38.04
37.26
g/l
0.44
25
127
13
39
3.39
3.24
1.7
1.1
—
—
—
0
0
10
24
4.22
3.20
1.2
1.0
—
—
—
0
0
20
85
2.40
3.18
1.2
1.1
—
—
—
0
0
11
30
3.72
3.10
1.1
1.1
—
—
—
0
0
22
99
2.27
3.10
1.1
1.1
—
—
—
0
0
9
21
4.34
3.00
1.2
1.3
—
—
—
0
0
14
52
2.73
2.90
1.9
1.6
—
—
—
0
0
14
52
2.73
2.90
1.9
1.6
—
—
—
0
0
11
33
3.38
2.82
1.5
1.2
—
—
—
0
0
21
97
2.21
2.80
1.1
1.5
—
—
—
0
0
12
39
3.12
2.78
1.3
1.1
—
—
—
0
0
149
1164
1.38
2.77
1.7
1.6
1.43
1.30
mmol/l
1.02
125
960
7
14
5.05
2.73
1.6
1.2
—
—
—
0
0
43
259
1.71
2.69
3.7
3.3
24.32
23.92
mmol/l
0.34
43
253
8
19
4.25
2.68
1.5
1.3
—
—
—
0
0
7
15
4.71
2.60
3.7
2.5
116.29
111.80
%
—
7
15
5
7
7.19
2.55
1.2
1.1
—
—
—
0
0
8
21
3.85
2.47
1.1
1.3
—
—
—
0
0
13
51
2.58
2.46
2.7
2.1
—
—
—
0
0
20
96
2.12
2.45
2.1
1.8
—
—
—
0
0
13
52
2.53
2.37
26.2
6.5
7.22
6.17
mmol/l
0.81
13
42
12
46
2.64
2.37
2.2
2.2
703.94
6636.72
u/l
—
7
14
14
59
2.41
2.31
4.1
3.9
—
—
—
0
0
16
72
2.26
2.29
1.3
1.3
—
—
—
0
0
21
107
2.00
2.23
12.7
5.9
106.14
104.85
mmol/l
0.77
21
95
(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay
5
9
5.59
2.21
1.0
1.4
92.60
109.67
%
—
5
9
6
14
4.32
2.15
1.2
1.2
—
—
—
0
0
73
526
1.44
2.15
6.2
3.6
—
—
—
0
0
148
1199
1.32
2.13
4.7
4.5
21.50
21.78
%
0.07
71
608
23
124
1.89
2.10
1.1
1.3
—
—
—
0
0
14
62
2.29
2.09
1.2
1.1
—
—
—
0
0
11
43
2.59
2.09
1.3
1.7
—
—
—
0
0
10
37
2.73
2.08
1.4
1.1
—
—
—
0
0
5
10
5.03
2.07
1.8
1.5
—
—
—
0
0
63
445
1.47
2.06
2.9
2.5
4.50
4.36
kpa
0.26
63
426
23
125
1.87
2.05
2.0
1.8
—
—
—
0
0
13
57
2.31
1.99
1.2
1.2
—
—
—
0
0
5
11
4.57
1.94
1.8
1.0
1992.00
1683.36
miu/ml
—
5
11
(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay
5
11
4.57
1.94
1.2
3.5
279.60
114.27
%
—
5
11
22
121
1.85
1.91
1.6
1.4
—
—
—
0
0
22
121
1.85
1.91
1.6
1.4
—
—
—
0
0
52
360
1.49
1.89
1.9
1.6
1.43
1.60
%
1.03
47
309
27
159
1.73
1.89
1.3
1.2
—
—
—
0
0
27
160
1.72
1.85
1.3
1.2
—
—
—
0
0
175
1481
1.26
1.76
5.4
5.3
2.51
3.40
ug/l
0.63
151
1305
5
13
3.87
1.72
1.8
1.0
8.93
8.67
ug/l
—
5
13
8
31
2.60
1.66
2.0
1.5
83.75
79.00
umol/l
—
8
31
39
264
1.51
1.60
2.3
2.1
12.52
12.29
nmol/l
0.04
27
224
6
20
3.02
1.58
1.2
1.3
—
—
—
0
0
11
50
2.22
1.58
3.0
2.1
—
—
—
0
0
7
28
2.52
1.45
1.3
1.3
—
—
—
0
0
7
28
2.52
1.45
1.3
1.3
—
—
—
0
0
7
28
2.52
1.45
3.9
3.6
—
—
—
0
0
6
23
2.63
1.37
1.0
1.6
—
—
—
0
0
6
23
2.63
1.37
1.0
1.6
—
—
—
0
0
77
611
1.30
1.30
13.6
7.6
—
—
—
0
0
10
48
2.10
1.28
1.0
1.0
—
—
—
0
0
10
49
2.06
1.22
1.1
1.3
0.55
0.61
nmol/l
—
10
44
35
247
1.44
1.22
2.6
1.8
—
—
—
0
0
67
528
1.30
1.20
1.8
1.4
—
—
—
0
0
74
592
1.29
1.19
4.6
4.6
30.04
33.08
%
1.90
53
381
6
26
2.32
1.19
1.5
2.2
—
—
—
0
0
5
20
2.51
1.15
1.4
1.3
—
—
—
0
0
5
20
2.51
1.15
1.4
1.3
—
—
—
0
0
36
259
1.42
1.14
4.1
3.1
0.39
0.23
e6/l
0.28
36
253
5
21
2.39
1.09
4.0
2.2
—
—
—
0
0
5
21
2.39
1.09
1.4
1.2
142.66
156.30
pmol/l
—
5
21
5
21
2.39
1.09
4.0
2.2
—
—
—
0
0
5
21
2.39
1.09
4.0
2.2
—
—
—
0
0
15
241
0.61
1.07
1.7
1.7
—
—
—
0
0
5
22
2.28
1.03
1.4
1.8
0.85
0.97
g/l
—
5
22
30
216
1.41
0.97
1.2
1.3
—
—
—
0
0
17
109
1.58
0.94
1.2
1.3
—
—
—
0
0
31
227
1.39
0.92
2.6
1.6
—
—
—
0
0
101
867
1.20
0.89
3.4
3.1
0.80
0.84
ug/l
0.08
64
598
20
138
1.47
0.82
1.3
1.4
350.42
267.92
ug/g
1.75
12
79
6
32
1.88
0.82
3.2
1.7
—
—
—
0
0
9
53
1.71
0.75
1.1
1.0
—
—
—
0
0
7
38
1.85
0.73
1.1
1.6
—
—
—
0
0
10
60
1.68
0.72
1.4
1.7
—
—
—
0
0
11
68
1.63
0.72
1.4
2.8
40.20
25.78
mg/l
—
5
17
15
101
1.50
0.70
2.7
1.7
—
—
—
0
0
14
95
1.49
0.64
1.1
1.1
—
—
—
0
0
5
30
1.67
0.61
3.0
2.5
—
—
—
0
0
0
20
0.00
0.60
0.0
1.2
—
—
—
0
0
29
230
1.27
0.56
1.2
1.2
232.18
135.17
iu/ml
—
9
87
6
37
1.63
0.55
1.5
1.9
—
—
—
0
0
6
37
1.63
0.55
1.5
1.3
0.29
0.34
nmol/l
—
6
28
61
535
1.16
0.46
1.5
1.4
—
—
—
0
0
61
547
1.13
0.36
2.5
4.0
4.74
35.14
ug/l
1.31
52
459
5
38
1.32
0.23
1.2
1.1
1.71
1.58
nmol/l
—
5
31
8
103
0.77
0.21
1.8
1.3
—
—
—
0
0
0
14
0.00
0.20
0.0
1.3
—
8.44
—
0
14
6
51
1.18
0.19
1.3
1.2
8.07
7.96
mmol/l
—
6
40
6
79
0.76
0.15
1.3
1.4
—
—
—
0
0
10
83
1.21
0.15
2.6
1.7
42.50
43.66
nmol/l
—
10
77
5
44
1.14
0.10
1.6
1.3
—
—
—
0
0
20
193
1.04
0.01
1.1
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
4.2
—
59.00
—
0
5
0
8
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.0
—
32.13
—
0
6
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
4.2
—
7.52
—
0
5
Mortality – FinRegistry
↥Association
Association between endpoint G6_POSTZOST and mortality.
Females
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| G6_POSTZOST | 1.259 [1.07, 1.48] | 0.005 |
| Birth year | 0.995 [0.99, 1.0] | 0.291 |
During the follow-up period (1.1.1998 — 31.12.2019), 668 out of 1848 females with G6_POSTZOST died.
Males
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| G6_POSTZOST | 1.483 [1.21, 1.82] | < 0.001 |
| Birth year | 0.99 [0.98, 1.0] | 0.031 |
During the follow-up period (1.1.1998 — 31.12.2019), 466 out of 1086 males with G6_POSTZOST died.
Mortality risk
Mortality risk for people of age
years, who have G6_POSTZOST.| N-year risk | Females | Males |
|---|---|---|
| 1 | 0.109% | 0.277% |
| 5 | 0.642% | 1.793% |
| 10 | 1.732% | 4.78% |
| 15 | 3.376% | 8.816% |
| 20 | 6.006% | 14.731% |
Relationships between endpoints
↥Index endpoint: G6_POSTZOST – Postzoster neuralgia
GWS hits: -
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data